-
1
-
-
84861760091
-
Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: A systematic review
-
Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev. 2012;16(4):309-339.
-
(2012)
Sleep Med Rev.
, vol.16
, Issue.4
, pp. 309-339
-
-
Innes, K.E.1
Selfe, T.K.2
Agarwal, P.3
-
2
-
-
84875181382
-
Restless legs syndrome: A comprehensive overview on its epidemiology, risk factors, and treatment
-
Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012;16(4):987-1007.
-
(2012)
Sleep Breath.
, vol.16
, Issue.4
, pp. 987-1007
-
-
Yeh, P.1
Walters, A.S.2
Tsuang, J.W.3
-
3
-
-
79960622082
-
Prevalence of restless legs syndrome in North American and Western European populations: A systematic review
-
Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med. 2011;12(7):623-634.
-
(2011)
Sleep Med.
, vol.12
, Issue.7
, pp. 623-634
-
-
Innes, K.E.1
Selfe, T.K.2
Agarwal, P.3
-
4
-
-
33845783867
-
Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome
-
Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007;120(1Suppl 1):S4-S12.
-
(2007)
Am J Med.
, vol.120
, Issue.1 SUPPL. 1
-
-
Kushida, C.A.1
-
5
-
-
84879152037
-
Restless legs syndrome: Pathophysiology and modern management
-
Nagandla K, De S. Restless legs syndrome: pathophysiology and modern management. Postgrad Med J. 2013;89(1053):402-410.
-
(2013)
Postgrad Med J.
, vol.89
, Issue.1053
, pp. 402-410
-
-
Nagandla, K.1
De, S.2
-
6
-
-
77649091106
-
Randomized trials of dopamine agonists in restless legs syndrome: A systematic review, quality assessment, and meta-analysis
-
Zintzaras E, Kitsios GD, Papathanasiou AA, et al. Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis. Clin Ther. 2010;32(2):221-237.
-
(2010)
Clin Ther.
, vol.32
, Issue.2
, pp. 221-237
-
-
Zintzaras, E.1
Kitsios, G.D.2
Papathanasiou, A.A.3
-
7
-
-
33747435873
-
Considering the causes of RLS
-
Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006;13 Suppl 3:S8-S14.
-
(2006)
Eur J Neurol.
, vol.13
, Issue.SUPPL. 3
-
-
Winkelman, J.W.1
-
8
-
-
67349112729
-
Iron, the substantia nigra and related neurological disorders
-
Snyder AM, Connor JR. Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta. 2009;1790(7):606-614.
-
(2009)
Biochim Biophys Acta.
, vol.1790
, Issue.7
, pp. 606-614
-
-
Snyder, A.M.1
Connor, J.R.2
-
9
-
-
0035936633
-
MRI measurement of brain iron in patients with restless legs syndrome
-
Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263-265.
-
(2001)
Neurology.
, vol.56
, Issue.2
, pp. 263-265
-
-
Allen, R.P.1
Barker, P.B.2
Wehrl, F.3
Song, H.K.4
Earley, C.J.5
-
11
-
-
0034331356
-
Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine
-
Shinpo K, Kikuchi S, Sasaki H, Moriwaka F, Tashiro K. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res. 2000;62(3):374-382.
-
(2000)
J Neurosci Res.
, vol.62
, Issue.3
, pp. 374-382
-
-
Shinpo, K.1
Kikuchi, S.2
Sasaki, H.3
Moriwaka, F.4
Tashiro, K.5
-
12
-
-
0030779127
-
The role of glutathione in dopaminergic neuronal survival
-
Nakamura K, Wang W, Kang UJ. The role of glutathione in dopaminergic neuronal survival. J Neurochem. 1997;69(5):1850-1858.
-
(1997)
J Neurochem.
, vol.69
, Issue.5
, pp. 1850-1858
-
-
Nakamura, K.1
Wang, W.2
Kang, U.J.3
-
13
-
-
0038334298
-
Review of the concept of vitamin D "sufficiency and insufficiency"
-
Spanish
-
Gómez Alonso C, Naves Díaz M, Rodríguez García M, Fernández Martín JL, Cannata Andía JB. [Review of the concept of vitamin D "sufficiency and insufficiency"]. Nefrologia. 2003;23Suppl 2:S73-S77. Spanish.
-
(2003)
Nefrologia.
, vol.23
, Issue.SUPPL. 2
-
-
Gómez Alonso, C.1
Naves Díaz, M.2
Rodríguez García, M.3
Fernández Martín, J.L.4
Cannata Andía, J.B.5
-
14
-
-
0037738587
-
Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health
-
Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group
-
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-119.
-
(2003)
Sleep Med.
, vol.4
, Issue.2
, pp. 101-119
-
-
Allen, R.P.1
Picchietti, D.2
Hening, W.A.3
Trenkwalder, C.4
Walters, A.S.5
Montplaisi, J.6
-
15
-
-
84874218195
-
A clinical primer on restless legs syndrome: What we know, and what we don't know
-
Sethi KD, Mehta SH. A clinical primer on restless legs syndrome: what we know, and what we don't know. Am J Manag Care. 2012; 18(5Suppl):S83-S88.
-
(2012)
Am J Manag Care.
, vol.18
, Issue.5 SUPPL.
-
-
Sethi, K.D.1
Mehta, S.H.2
-
16
-
-
0042626103
-
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
-
Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304-309.
-
(2003)
Neurology.
, vol.61
, Issue.3
, pp. 304-309
-
-
Connor, J.R.1
Boyer, P.J.2
Menzies, S.L.3
-
18
-
-
84885136041
-
Imaging brain functional and metabolic changes in restless legs syndrome
-
Rizzo G, Tonon C, Manners D, Testa C, Lodi R. Imaging brain functional and metabolic changes in restless legs syndrome. Curr Neurol Neurosci Rep. 2013;13(9):372.
-
(2013)
Curr Neurol Neurosci Rep.
, vol.13
, Issue.9
, pp. 372
-
-
Rizzo, G.1
Tonon, C.2
Manners, D.3
Testa, C.4
Lodi, R.5
-
19
-
-
0036166731
-
SPECT imaging of striatal pre-and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep
-
Michaud M, Soucy JP, Chabli A, Lavigne G, Montplaisir J. SPECT imaging of striatal pre-and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002;249(2):164-170.
-
(2002)
J Neurol.
, vol.249
, Issue.2
, pp. 164-170
-
-
Michaud, M.1
Soucy, J.P.2
Chabli, A.3
Lavigne, G.4
Montplaisir, J.5
-
20
-
-
0033596829
-
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies
-
Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology. 1999;52(5):932-937.
-
(1999)
Neurology.
, vol.52
, Issue.5
, pp. 932-937
-
-
Turjanski, N.1
Lees, A.J.2
Brooks, D.J.3
-
21
-
-
0034711709
-
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome
-
Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 2000;54(2):502-504.
-
(2000)
Neurology.
, vol.54
, Issue.2
, pp. 502-504
-
-
Ruottinen, H.M.1
Partinen, M.2
Hublin, C.3
-
22
-
-
71549117331
-
Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome
-
Connor JR, Wang XS, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132(Pt 9):2403-2412.
-
(2009)
Brain.
, vol.132
, Issue.PART 9
, pp. 2403-2412
-
-
Connor, J.R.1
Wang, X.S.2
Allen, R.P.3
-
23
-
-
0037295384
-
Genetic association of Huntington's disease and restless legs syndrome? A family report
-
Evers S, Stögbauer F. Genetic association of Huntington's disease and restless legs syndrome? A family report. Mov Disord. 2003;18(2): 225-227.
-
(2003)
Mov Disord.
, vol.18
, Issue.2
, pp. 225-227
-
-
Evers, S.1
Stögbauer, F.2
-
24
-
-
33646259696
-
Association between restless legs syndrome and essential tremor
-
Ondo WG, Lai D. Association between restless legs syndrome and essential tremor. Mov Disord. 2006;21(4):515-518.
-
(2006)
Mov Disord.
, vol.21
, Issue.4
, pp. 515-518
-
-
Ondo, W.G.1
Lai, D.2
-
25
-
-
4644272641
-
Restless legs in Tourette syndrome
-
Montréal Tourette Study Group
-
Lespérance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F; Montréal Tourette Study Group. Restless legs in Tourette syndrome. Mov Disord. 2004;19(9):1084-1087.
-
(2004)
Mov Disord.
, vol.19
, Issue.9
, pp. 1084-1087
-
-
Lespérance, P.1
Djerroud, N.2
Diaz Anzaldua, A.3
Rouleau, G.A.4
Chouinard, S.5
Richer, F.6
-
26
-
-
38049072727
-
The role of iron in restless legs syndrome
-
Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22Suppl 18:S440-S448.
-
(2007)
Mov Disord.
, vol.22
, Issue.SUPPL. 18
-
-
Allen, R.P.1
Earley, C.J.2
-
27
-
-
0032525409
-
Iron and the restless legs syndrome
-
Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep. 1998;21(4):371-377.
-
(1998)
Sleep.
, vol.21
, Issue.4
, pp. 371-377
-
-
Sun, E.R.1
Chen, C.A.2
Ho, G.3
Earley, C.J.4
Allen, R.P.5
-
29
-
-
84887626041
-
Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging
-
Rizzo G, Manners D, Testa C, et al. Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging. Mov Disord. 2013;28(13):1886-1890.
-
(2013)
Mov Disord.
, vol.28
, Issue.13
, pp. 1886-1890
-
-
Rizzo, G.1
Manners, D.2
Testa, C.3
-
30
-
-
79955507698
-
Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction
-
Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr. 2011;141(4):740-746.
-
(2011)
J Nutr.
, vol.141
, Issue.4
, pp. 740-746
-
-
Lozoff, B.1
-
31
-
-
84883286550
-
Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice
-
Jellen LC, Lu L, Wang X, et al. Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Neuroscience. 2013;252:13-23.
-
(2013)
Neuroscience.
, vol.252
, pp. 13-23
-
-
Jellen, L.C.1
Lu, L.2
Wang, X.3
-
32
-
-
0036550614
-
New clues about vitamin D functions in the nervous system
-
Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13(3):100-105.
-
(2002)
Trends Endocrinol Metab.
, vol.13
, Issue.3
, pp. 100-105
-
-
Garcion, E.1
Wion-Barbot, N.2
Montero-Menei, C.N.3
Berger, F.4
Wion, D.5
-
33
-
-
0032797944
-
1,25-dihydroxyvitamin D3regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes
-
Garcion E, Sindji L, Leblondel G, Brachet P, Darcy F. 1,25-dihydroxyvitamin D3regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem. 1999;73(2):859-866.
-
(1999)
J Neurochem.
, vol.73
, Issue.2
, pp. 859-866
-
-
Garcion, E.1
Sindji, L.2
Leblondel, G.3
Brachet, P.4
Darcy, F.5
-
34
-
-
84876539226
-
Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression
-
Orme RP, Bhangal MS, Fricker RA. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS One. 2013;8(4):e62040.
-
(2013)
PLoS One.
, vol.8
, Issue.4
-
-
Orme, R.P.1
Bhangal, M.S.2
Fricker, R.A.3
-
35
-
-
84863863686
-
Serum 25-hydroxyvitamin D levels in restless legs syndrome patients
-
Balaban H, Yi{dotless}ldi{dotless}z ÖK, Çil G, et al. Serum 25-hydroxyvitamin D levels in restless legs syndrome patients. Sleep Med. 2012;13(7):953-957.
-
(2012)
Sleep Med.
, vol.13
, Issue.7
, pp. 953-957
-
-
Balaban, H.1
Yildiz, O.K.2
Çil, G.3
|